Skip to main content
. 2021 Dec 3;14:5385–5389. doi: 10.2147/OTT.S335736

Figure 2.

Figure 2

Brain MRI with contrast demonstrating one brain metastatic lesion (red arrows), (A) is at diagnosis, (B) following 6 months of alectinib treatment, and (C) following 9 months of alectinib.